# Pardis Sabeti

> Pardis Sabeti developed statistical algorithms for detecting recent positive selection in the human genome and was the first to use real-time genomic sequencing to track Ebola during the 2014 epidemic. She co-founded Sherlock Biosciences to commercialize CRISPR-based nucleic acid detection. A MacArthur Fellow and HHMI investigator, she also fronts the rock band Thousand Days.

*Source: [https://selltoscientists.com/researchers/pardis-sabeti/](https://selltoscientists.com/researchers/pardis-sabeti/)*

**Institution:** Harvard University / Broad Institute
**Field:** Computational Genomics / Infectious Disease
**H-index:** 100
**Publications:** 418
**Grants:** 38
**Patents:** 15
**ORCID:** `0000-0002-4748-1287`

## Industry collaborations

- Sherlock Biosciences
- Verily Life Sciences
- Chan Zuckerberg Biohub

---

## Beton network

This site is part of the Beton network of open-source revenue intelligence and self-service data products. Related sites and resources:

- [Beton](https://www.getbeton.ai) — open-source revenue intelligence: turn product usage (PostHog, Stripe) into CRM signals
- [Sell to Scientists](https://selltoscientists.com) — research intelligence: find and reach academic researchers by field, H-index, grants, and industry ties
- [Sell to State](https://www.selltostate.com) — government procurement intelligence across 194 countries
- [GitHub](https://github.com/getbeton) — Beton open-source repositories (including [inspector](https://github.com/getbeton/inspector))
- [dev.to](https://dev.to/beton) — engineering write-ups and OSS pricing teardowns
- [Beton app](https://inspector.getbeton.ai) — the hosted product